Company to share preclinical data on the use of integrated circuit T cells for the development of cell therapies for the treatment of kidney and other solid tumor cancersSOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) #AACR23 Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company e.